M. Liset Rietman

Dr. M. Liset Rietman


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2016 in The Journal of nutrition, health and aging
Verified
Journal Article
Open access
PDF file
MRM. Liset Rietman
M. Liset Rietman
DAD. L. van der A
D. L. van der A
SOS. H. van Oostrom
S. H. van Oostrom
HPH. S. J. Picavet
H. S. J. Picavet
MDM. E. T. Dollé
M. E. T. Dollé
ASA. M. W. Spijkerman
A. M. W. Spijkerman
Previous studies showed a U-shaped association between BMI and (physical) frailty. We studied the association between BMI and physical, cognitive, psychological, and social frailty. Furthermore, the overlap between and prevalence of these frailty domains was examined. Cross-sectional study. The Doetinchem Cohort Study is a longitudinal population-based study starting in 1987-1991 examining men and women aged 20-59 with follow-up examinations every 5 yrs. For the current analyses, we used data from round 5 (2008-2012) with 4019 participants aged 41-81 yrs. Physical frailty was defined as having ≥ 2 of 4 frailty criteria from the Frailty Phenotype (unintentional weight loss, exhaustion, physical activity, handgrip strength). Cognitive frailty was defined as the < 10th percentile on global cognitive functioning (based on memory, speed, flexibility). Psychological frailty was defined as having 2 out of 2 criteria (depression, mental health). Social frailty was defined as having ≥ 2 of 3 criteria (loneliness, social support, social participation). BMI was divided into four classes. Analyses were adjusted for sex, age, level of education, and smoking. A U-shaped association was observed between BMI and physical frailty, a small linear association for BMI and cognitive frailty and no association between BMI and psychological and social frailty. The four frailty domains showed only a small proportion of overlap. The prevalence of physical, cognitive and social frailty increased with age, whereas psychological frailty did not. We confirm that not only underweight but also obesity is associated with physical frailty. Obesity also seems to be associated with cognitive frailty. Further, frailty prevention should focus on multiple domains and target individuals at a younger age (<65yrs).

1 January 2019 in Mechanisms of Ageing and Development
Verified
Journal Article
Closed access
MRM. Liset Rietman
M. Liset Rietman
ASAnnemieke M.W. Spijkerman
Annemieke M.W. Spijkerman
AWAlbert Wong
Albert Wong
HSHarry van Steeg
Harry van Steeg
ABAlexander Bürkle
Alexander Bürkle
MDMartijn E.T. Dollé
Martijn E.T. Dollé

10 January 2023 in Gerontology
Verified
Journal Article
Open access
PDF file
RGRobertina Giacconi
Robertina Giacconi
Blanca LaffonBlanca Laffon
Blanca Laffon
SCSolange Costa
Solange Costa
ATArmanda Teixeira-Gomes
Armanda Teixeira-Gomes
FMFabrizio Maggi
Fabrizio Maggi
Marco MalavoltaMarco Malavolta
Marco Malavolta
Introduction: Immunosenescence and inflammaging have been implicated in the pathophysiology of frailty. Torquetenovirus (TTV), a single-stranded DNA anellovirus, the major component of the human blood virome, shows an increased replication rate with advancing age. An elevated TTV viremia has been associated with an impaired immune function and an increased risk of mortality in the older population. The objective of this study was to analyze the relation between TTV viremia, physical frailty, and cognitive impairment. Methods: TTV viremia was measured in 1,131 nonfrail, 45 physically frail, and 113 cognitively impaired older adults recruited in the MARK-AGE study (overall mean age 64.7 ± 5.9 years), and then the results were checked in two other independent cohorts from Spain and Portugal, including 126 frail, 252 prefrail, and 141 nonfrail individuals (overall mean age: 77.5 ± 8.3 years). Results: TTV viremia ≥4log was associated with physical frailty (OR: 4.69; 95% CI: 2.06–10.67, p < 0.0001) and cognitive impairment (OR: 3.49, 95% CI: 2.14–5.69, p < 0.0001) in the MARK-AGE population. The association between TTV DNA load and frailty status was confirmed in the Spanish cohort, while a slight association with cognitive impairment was observed (OR: 1.33; 95% CI: 1.000–1.773), only in the unadjusted model. No association between TTV load and frailty or cognitive impairment was found in the Portuguese sample, although a negative association between TTV viremia and MMSE score was observed in Spanish and Portuguese females. Conclusions: These findings demonstrate an association between TTV viremia and physical frailty, while the association with cognitive impairment was observed only in the younger population from the MARK-AGE study. Further research is necessary to clarify TTV’s clinical relevance in the onset and progression of frailty and cognitive decline in older individuals.

31 May 2019 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
MRM. Liset Rietman
M. Liset Rietman
GHGerben Hulsegge
Gerben Hulsegge
ANAstrid C. J. Nooyens
Astrid C. J. Nooyens
MDMartijn E. T. Dollé
Martijn E. T. Dollé
HPH. Susan J. Picavet
H. Susan J. Picavet
WVW. M. Monique Verschuren
W. M. Monique Verschuren
Background: Long-term changes in (bio)markers for cognitive frailty are not well characterized. Therefore, our aim is to explore (bio)marker trajectories in adults who became cognitively frail compared to age- and sex-matched controls who did not become cognitively frail over a 15 year follow-up. We hypothesize that those who become cognitively frail have more unfavorable trajectories of (bio)markers compared to controls. Methods: The Doetinchem Cohort Study is a longitudinal population-based study that started in 1987–1991 in men and women aged 20–59 years, with follow-up examinations every 5 years. For the current analyses, we used data of 17 potentially relevant (bio)markers (e.g., body mass index (BMI), urea) from rounds 2 to 5 (1993–2012). A global cognitive functioning score (based on memory, speed, and flexibility) was calculated for each round and transformed into education and examination round-adjusted z-scores. The z-score that corresponded to the 10th percentile in round 5 (z-score = −0.77) was applied as cut-off point for incident cognitive frailty in rounds 2–5. In total, 455 incident cognitively frail cases were identified retrospectively and were compared with 910 age- and sex-matched controls. Trajectories up to 15 years before and 10 years after incident cognitive frailty were analyzed using generalized estimating equations with stratification for sex and adjustment for age and, if appropriate, medication use. Results were further adjusted for level of education, depressive symptoms, BMI, and lifestyle factors. Results: In men, (bio)marker trajectories did not differ as they ran parallel and the difference in levels was not statistically significant between those who became cognitively frail compared to controls. In women, total cholesterol trajectories first increased and thereafter decreased in cognitively frail women and steadily increased in controls, gamma-glutamyltransferase trajectories were more or less stable in cognitively frail women and increased in controls, and urea trajectories increased in cognitively frail women and remained more or less stable in controls. Results were similar after additional adjustment for potential confounders. Conclusions: Out of the 17 (bio)markers included in this explorative study, differential trajectories for three biomarkers were observed in women. We do not yet consider any of the studied (bio)markers as promising biomarkers for cognitive frailty.

17 March 2026 in International Journal of Obesity
Verified
Journal Article
Open access
PDF file
FHFemke Te Hoonte
Femke Te Hoonte
MRM. Liset Rietman
M. Liset Rietman
KWKirsten E. J. Wesenhagen
Kirsten E. J. Wesenhagen
HPH. Susan J. Picavet
H. Susan J. Picavet
WVW. M. Monique Verschuren
W. M. Monique Verschuren
Background Having obesity is a risk factor for cognitive decline and dementia. It remains unclear whether timing of obesity during someone’s lifespan affects this association. Aim To study the association of body mass index (BMI), waist circumference (WC), and having (abdominal) overweight and obesity with cognitive function and decline, and whether these associations were modified by age. Methods 3873 participants (aged 45–70 at baseline, 52% women) from the Doetinchem Cohort Study were included, with up to six repeated measures. Participants were classified as having (abdominal) obesity if they had a BMI ≥30 kg/m² or WC ≥102 cm (men) or ≥88 cm (women). Domain scores for global cognition, memory, flexibility, and processing speed were calculated by standardizing individual test scores at baseline. Associations of time-dependent BMI, WC, and (abdominal) overweight and obesity with cognitive function and decline were studied using linear mixed models. Models were sex-stratified and adjusted for socio-demographic, lifestyle, and mental health factors. Modification by age (≤ or >55 years at baseline) was evaluated using interaction terms. Results Higher BMI and WC were associated with worse level of cognition (all domains). For both sexes, the smallest difference was for global cognition (BMI) and processing speed (WC), the largest for flexibility (BMI) and memory (WC). Furthermore, having (abdominal) obesity, compared to a healthy BMI/WC, was consistently associated with worse memory function in both sexes. Effect sizes were generally larger for categorical WC compared to categorical BMI. In men, abdominal obesity was associated with accelerated decline in processing speed (all ages), and with accelerated decline in global cognition and flexibility ( > 55 years). Conclusions In both sexes, higher BMI and WC were consistently associated with worse cognition. WC-based overweight and obesity showed larger effect sizes with cognition than BMI-based overweight and obesity. Only in men, associations with cognitive decline and effect modification by age were observed.

4 November 2024 in Age and Ageing
Verified
Journal Article
Open access
PDF file
ASAnnelot P Smit
Annelot P Smit
GHGerrie-Cor M Herber
Gerrie-Cor M Herber
LKLieke M Kuiper
Lieke M Kuiper
MRM. Liset Rietman
M. Liset Rietman
KWKirsten E J Wesenhagen
Kirsten E J Wesenhagen
WVW M Monique Verschuren
W M Monique Verschuren
Metabolomic scores based on age (MetaboAge) and mortality (MetaboHealth) are considered indicators of overall health, but their association with cognition in the general population is unknown. Therefore, the association between MetaboAge/MetaboHealth and level and decline in cognition was studied, as were differences between men and women. Data of 2821 participants (50% women, age range 45–75) from the Doetinchem Cohort Study was used. MetaboAge and MetaboHealth were calculated from 1H-NMR metabolomics data at baseline. Cognitive domain scores (memory, flexibility and processing speed) and global cognitive functioning were available over a 10-year period. The association between MetaboAge/MetaboHealth and level of cognitive functioning was studied using linear regressions while for the association between MetaboAge/MetaboHealth and cognitive decline longitudinal linear mixed models were used. Analyses were adjusted for demographics and lifestyle factors. Higher MetaboAge, indicating poorer metabolomic ageing, was only associated with lower levels of processing speed in men. Higher MetaboHealth, indicating poorer immune-metabolic health, was associated with lower levels of cognitive functioning for all three domains and global cognitive functioning in both men and women. Only in men, MetaboHealth was also associated with 10-year decline in flexibility, processing speed and global cognition. Metabolites that contributed to the observed associations were in men mainly markers of protein metabolism, and in women mainly markers of lipid metabolism and inflammatory metabolites. MetaboHealth, not MetaboAge, was associated with cognitive functioning independent of conventional risk factors. Individual metabolites affect cognitive functioning differently in men and women, suggesting sex-specific pathophysiological pathways underlying cognitive functioning.